IL4 and mastocytosis: In contrast to these findings, suggesting that increased IL-4 and/or IL-13 signaling may limit MC numbers and disease severity in patients with CM, Nedoszytko et al. [27] identified a distinct pattern associated with IL-13 in patients with mastocytosis—Table 2.